Evidence map›Paper›PMID 28228527›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Activation mechanism of the G protein-coupled sweet receptor heterodimer with sweeteners and allosteric agonists.

Soo-Kyung Kim, Yalu Chen, Ravinder Abrol, William A Goddard, Brian Guthrie

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 90 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Molecular Dynamics Insights into TAS1R2 Transmembrane Domain Activation.International journal of molecular sciences · 2025
    Article
  6. Article
  7. Nutrients · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. The neural basis of sugar preference.Nature reviews. Neuroscience · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Soo-Kyung KimMaterials and Process Simulation Center (MC 139-74), California Institute of Technology, Pasadena, CA 91125; wag@wag.caltech.edu skkim@wag.caltech.edu.
Yalu ChenMaterials and Process Simulation Center (MC 139-74), California Institute of Technology, Pasadena, CA 91125.
Ravinder AbrolMaterials and Process Simulation Center (MC 139-74), California Institute of Technology, Pasadena, CA 91125.
William A GoddardMaterials and Process Simulation Center (MC 139-74), California Institute of Technology, Pasadena, CA 91125; wag@wag.caltech.edu skkim@wag.caltech.edu.ORCID 0000-0003-0097-5716
Brian GuthrieCargill Global Food Research, Wayzata, MN 55391.
California Institute of Technology · USCargill (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sweet taste in humans is mediated by the TAS1R2/TAS1R3 G protein-coupled receptor (GPCR), which belongs to the class C family that also includes the metabotropic glutamate and γ-aminobutyric acid receptors. We report here the predicted 3D structure of the full-length TAS1R2/TAS1R3 heterodimer, including the Venus Flytrap Domains (VFDs) [in the closed-open (co) active conformation], the cysteine-rich domains (CRDs), and the transmembrane domains (TMDs) at the TM56/TM56 interface. We observe that binding of agonists to VFD2 of TAS1R2 leads to major conformational changes to form a TM6/TM6 interface between TMDs of TAS1R2 and TAS1R3, which is consistent with the activation process observed biophysically on the metabotropic glutamate receptor 2 homodimer. We find that the initial effect of the agonist is to pull the bottom part of VFD3/TAS1R3 toward the bottom part of VFD2/TAS1R2 by ∼6 Å and that these changes get transmitted from VFD2 of TAS1R2 (where agonists bind) through the VFD3 and the CRD3 to the TMD3 of TAS1R3 (which couples to the G protein). These structural transformations provide a detailed atomistic mechanism for the activation process in GPCR, providing insights and structural details that can now be validated through mutation experiments.

Indexed as

Protein ConformationAllosteric RegulationAnimalsCrystallography, X-RayHumansMutationProtein BindingProtein DomainsProtein MultimerizationReceptors, G-Protein-CoupledReceptors, Metabotropic GlutamateSweetening AgentsTasteTaste PerceptionReceptors, G-Protein-CoupledReceptors, Metabotropic GlutamateSweetening Agentstaste receptors, type 1class C GPCRGPCR activationmolecular dynamicsnoncaloric sweetener

Identifiers

PMID28228527
PMCPMC5347580
OpenAlexW2590360966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.